The Simtomax ® family of tests has been trialed in several clinical studies, with both prospective and retrospective setups.
Publications and Technical Briefs
You can download and read the results from our clinical studies here below:
|
Aim of the study
|
Document
|
- Performance evaluation of a DGP point-of-care test against tTG-based ELISA format on a large pediatric population.
|
Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population
European Journal of Gastroenterology&Hepatology, vol 24, issue 12, 2012
|
- Cost-Benefit analysis investigating the budgetary impact of replacing the current Celiac Disease screening process with the Simtomax® testing kit .
|
Simtomax®: a new screening tool for coeliac disease
British Journal of Healthcare Management 2012 Vol 18 No1
|
- Validation of the point-of-care test platform and its usefulness in a ward setting.
- Performance validation in prospective setting.
|
Validation of a New Point-of-Care Test for a Universal Screening of Celiac Disease
Journal of Pediatric Gastroenterology and Nutrition, vol 48, May 2009
|
- Assessment of the interpretation of the results on a point-of-care test platform.
- Performance validation in prospective setting.
|
Assessing Accuracy of Interpretation of a Rapid Celiac Assay in a Ward Setting
JPGN, vol50, suppl.2, June 2010
|
- Performance evaluation of a DGP point-of-care test against its equivalent on ELISA format.
|
Accuracy of a Rapid Celiac Disease Test Based on Deamidated Gliadin Peptides Is Comparable to an ELISA Laboratory Method
Augurix Technical Brief, May 2010
|
- Performance evaluation of a DGP point-of-care test against tTG-based ELISA format.
|
Comparison of a Deamidated Gliadin Peptides Rapid Test for Celiac Disease with a Commercial ELISA tTGbased Assay
Augurix Technical Brief, July 2010
|
Ongoing clinical studies
Further clinical evaluations are currently taking place in different countries in Europe and US. Please contact us for more details. |
